These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 37243620)
21. Noninvasive positron emission tomography imaging of cell death using a novel small-molecule probe, (18)F labeled bis(zinc(II)-dipicolylamine) complex. Wang H; Tang X; Tang G; Huang T; Liang X; Hu K; Deng H; Yi C; Shi X; Wu K Apoptosis; 2013 Aug; 18(8):1017-27. PubMed ID: 23613106 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and pre-clinical evaluation of a new class of high-affinity Kelly J; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Ponnala S; Babich JW Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):647-661. PubMed ID: 27847991 [TBL] [Abstract][Full Text] [Related]
23. A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer. Ganguly T; Dannoon S; Hopkins MR; Murphy S; Cahaya H; Blecha JE; Jivan S; Drake CR; Barinka C; Jones EF; VanBrocklin HF; Berkman CE Nucl Med Biol; 2015 Oct; 42(10):780-7. PubMed ID: 26169882 [TBL] [Abstract][Full Text] [Related]
24. In Vitro and In Vivo Characterization of an Lütje S; Franssen GM; Herrmann K; Boerman OC; Rijpkema M; Gotthardt M; Heskamp S J Nucl Med; 2019 Jul; 60(7):1017-1022. PubMed ID: 30655329 [TBL] [Abstract][Full Text] [Related]
25. Rational design of caspase-responsive smart molecular probe for positron emission tomography imaging of drug-induced apoptosis. Qiu L; Wang W; Li K; Peng Y; Lv G; Liu Q; Gao F; Seimbille Y; Xie M; Lin J Theranostics; 2019; 9(23):6962-6975. PubMed ID: 31660080 [No Abstract] [Full Text] [Related]
26. Design and Investigation of a [ Yang D; Comeau A; Bowen WD; Mach RH; Ross BD; Hong H; Van Dort ME Mol Pharm; 2017 Mar; 14(3):770-780. PubMed ID: 28135101 [TBL] [Abstract][Full Text] [Related]
27. STING-Targeted PET Imaging for Specific Detection and Therapeutic Monitoring of Myocarditis. Ye Z; Lu X; Zhu M; Bi L; Yang F; Zhou B; Xu D; Yao L Mol Pharm; 2024 Jun; 21(6):2865-2877. PubMed ID: 38666508 [TBL] [Abstract][Full Text] [Related]
28. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer. Heskamp S; Laverman P; Rosik D; Boschetti F; van der Graaf WT; Oyen WJ; van Laarhoven HW; Tolmachev V; Boerman OC J Nucl Med; 2012 Jan; 53(1):146-53. PubMed ID: 22173842 [TBL] [Abstract][Full Text] [Related]
29. Melanoma Imaging Using Zhang C; Zhang Z; Lin KS; Lau J; Zeisler J; Colpo N; Perrin DM; Bénard F Mol Pharm; 2018 Jun; 15(6):2116-2122. PubMed ID: 29714486 [TBL] [Abstract][Full Text] [Related]
30. A radiofluorinated divalent cystine knot peptide for tumor PET imaging. Jiang L; Kimura RH; Ma X; Tu Y; Miao Z; Shen B; Chin FT; Shi H; Gambhir SS; Cheng Z Mol Pharm; 2014 Nov; 11(11):3885-92. PubMed ID: 24717098 [TBL] [Abstract][Full Text] [Related]
31. PET imaging of EGFR expression using an Cheng S; Jacobson O; Zhu G; Chen Z; Liang SH; Tian R; Yang Z; Niu G; Zhu X; Chen X Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):948-956. PubMed ID: 30069577 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and Biologic Evaluation of a Novel Donnelly DJ; Smith RA; Morin P; Lipovšek D; Gokemeijer J; Cohen D; Lafont V; Tran T; Cole EL; Wright M; Kim J; Pena A; Kukral D; Dischino DD; Chow P; Gan J; Adelakun O; Wang XT; Cao K; Leung D; Bonacorsi SJ; Hayes W J Nucl Med; 2018 Mar; 59(3):529-535. PubMed ID: 29025984 [TBL] [Abstract][Full Text] [Related]
33. Pilot study of a novel (18)F-labeled FSHR probe for tumor imaging. Xu Y; Pan D; Zhu C; Xu Q; Wang L; Chen F; Yang R; Luo S; Yang M; Yan Y Mol Imaging Biol; 2014 Aug; 16(4):578-85. PubMed ID: 24389931 [TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo evaluation of a (18)F-labeled high affinity NOTA conjugated bombesin antagonist as a PET ligand for GRPR-targeted tumor imaging. Varasteh Z; Aberg O; Velikyan I; Lindeberg G; Sörensen J; Larhed M; Antoni G; Sandström M; Tolmachev V; Orlova A PLoS One; 2013; 8(12):e81932. PubMed ID: 24312607 [TBL] [Abstract][Full Text] [Related]
35. Gao F; Peng C; Zhuang R; Guo Z; Liu H; Huang L; Li H; Xu D; Wen X; Fang J; Zhang X Nucl Med Biol; 2019; 72-73():62-69. PubMed ID: 31330414 [TBL] [Abstract][Full Text] [Related]
36. PET of malignant melanoma using 18F-labeled metallopeptides. Ren G; Liu Z; Miao Z; Liu H; Subbarayan M; Chin FT; Zhang L; Gambhir SS; Cheng Z J Nucl Med; 2009 Nov; 50(11):1865-72. PubMed ID: 19837749 [TBL] [Abstract][Full Text] [Related]
37. Longitudinal PET imaging of muscular inflammation using 18F-DPA-714 and 18F-Alfatide II and differentiation with tumors. Wu C; Yue X; Lang L; Kiesewetter DO; Li F; Zhu Z; Niu G; Chen X Theranostics; 2014; 4(5):546-55. PubMed ID: 24672585 [TBL] [Abstract][Full Text] [Related]
38. A novel radiofluorinated agouti-related protein for tumor angiogenesis imaging. Jiang H; Moore SJ; Liu S; Liu H; Miao Z; Cochran FV; Liu Y; Tian M; Cochran JR; Zhang H; Cheng Z Amino Acids; 2013 Feb; 44(2):673-81. PubMed ID: 22945905 [TBL] [Abstract][Full Text] [Related]
39. One-step Zhao X; Lv G; Li K; Peng Y; Liu Q; Qiu L; Lin J Nucl Med Biol; 2020; 82-83():72-79. PubMed ID: 32109829 [TBL] [Abstract][Full Text] [Related]
40. [ Amor-Coarasa A; Kelly J; Ponnala S; Vedvyas Y; Nikolopoulou A; Williams C; Jin MM; David Warren J; Babich JW Nucl Med Biol; 2018 May; 60():37-44. PubMed ID: 29544122 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]